Skip to main content
SpringerLink
Log in

Asunaprevir/daclatasvir

Dermatitis and hepatic failure: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Taki S, et al. Real-world safety and efficacy of daclatasvir plus asnaprevir for elderly patients over 75 years of age. Hepatology International 11 (Suppl. 1): abstr. S303, No. 11, Feb 2017. Available from: URL: http://doi.org/10.1007/s12072-016-9783-9 [abstract] - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asunaprevir/daclatasvir. Reactions Weekly 1643, 46 (2017). https://doi.org/10.1007/s40278-017-27519-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-27519-x

Search

Navigation